HIV-2 gp36 is a glycoprotein found in the envelope of the Human Immunodeficiency Virus type 2 (HIV-2). This protein plays a crucial role in the virus’s ability to infect host cells and is a key target for diagnostic and therapeutic research. The recombinant form of HIV-2 gp36, specifically the 397 amino acid (aa) variant, is used extensively in laboratory research to study the virus’s properties and to develop diagnostic tools.
The HIV-2 gp36 397aa recombinant protein is a 34 kDa protein that contains 397 amino acids. It includes the sequence of the HIV-2 envelope immunodominant regions, which are critical for the virus’s ability to bind and enter host cells . The protein is often fused to beta-galactosidase at the N-terminus, which aids in its detection and purification during laboratory experiments .
The recombinant HIV-2 gp36 protein is typically expressed in Escherichia coli (E. coli) bacteria. This expression system is chosen because it allows for high-yield production of the protein, which is essential for research purposes. The protein is then purified to a high degree of purity, often greater than 95%, using techniques such as High-Performance Liquid Chromatography (HPLC) and Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) .
The HIV-2 gp36 397aa recombinant protein is used in various research applications, including: